These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38160647)

  • 1. The impact of depressive symptoms on cognitive impairments in chronic ketamine users.
    Zhang C; Zhang B; Xu Y; Hao W; Tang WK
    Compr Psychiatry; 2024 Feb; 129():152448. PubMed ID: 38160647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between cognitive impairment and depressive symptoms in current ketamine users.
    Tang WK; Liang HJ; Lau CG; Tang A; Ungvari GS
    J Stud Alcohol Drugs; 2013 May; 74(3):460-8. PubMed ID: 23490576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairments in poly-drug ketamine users.
    Liang HJ; Lau CG; Tang A; Chan F; Ungvari GS; Tang WK
    Addict Behav; 2013 Nov; 38(11):2661-6. PubMed ID: 23899429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The profile of cognitive impairments in chronic ketamine users.
    Ke X; Ding Y; Xu K; He H; Wang D; Deng X; Zhang X; Zhou Y; Zhou C; Liu Y; Ning Y; Fan N
    Psychiatry Res; 2018 Aug; 266():124-131. PubMed ID: 29864611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment in chronic ketamine abusers.
    Zhang C; Xu Y; Zhang B; Hao W; Tang WK
    Psychiatry Res; 2020 Sep; 291():113206. PubMed ID: 32763531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Other drug use does not impact cognitive impairments in chronic ketamine users.
    Zhang C; Tang WK; Liang HJ; Ungvari GS; Lin SK
    Drug Alcohol Depend; 2018 May; 186():1-8. PubMed ID: 29518690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study.
    Morgan CJ; Muetzelfeldt L; Curran HV
    Addiction; 2010 Jan; 105(1):121-33. PubMed ID: 19919593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls.
    Morgan CJ; Muetzelfeldt L; Curran HV
    Addiction; 2009 Jan; 104(1):77-87. PubMed ID: 19133891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Objective and Subjective Cognitive Function in Patients With Treatment-Resistant Depression Undergoing Repeated Ketamine Infusions.
    Phillips JL; Van Geel A; Burhunduli P; Vasudev D; Batten LA; Norris S; Talbot J; Ortiz A; Owoeye O; Blier P
    Int J Neuropsychopharmacol; 2022 Dec; 25(12):992-1002. PubMed ID: 35931041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling the psychotic, depressive and anxiety symptoms in chronic ketamine users.
    Fan N; Xu K; Ning Y; Rosenheck R; Wang D; Ke X; Ding Y; Sun B; Zhou C; Deng X; Tang W; He H
    Psychiatry Res; 2016 Mar; 237():311-5. PubMed ID: 26805565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar psychotic and cognitive profile between ketamine dependence with persistent psychosis and schizophrenia.
    Cheng WJ; Chen CH; Chen CK; Huang MC; Pietrzak RH; Krystal JH; Xu K
    Schizophr Res; 2018 Sep; 199():313-318. PubMed ID: 29510925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of cognitive functioning following abstinence from ketamine.
    Tang WK; Lau CG; Ungvari GS; Lin SK; Lane HY
    Addict Behav; 2019 Dec; 99():106081. PubMed ID: 31470241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive changes in patients with unipolar TRD treated with IV ketamine: A systematic review.
    Grasso V; Gutierrez G; Alzbeidi N; Hernandorena C; Vázquez GH
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Dec; 135():111095. PubMed ID: 39032855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic ketamine use on frontal and medial temporal cognition.
    Chan KW; Lee TM; Siu AM; Wong DP; Kam CM; Tsang SK; Chan CC
    Addict Behav; 2013 May; 38(5):2128-32. PubMed ID: 23435274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bi-factor model of the Montgomery Åsberg depression rating scale and future cognitive impairments in older adults: A 6-year follow-up study.
    Zuidersma M; Sjöberg L; Pantzar A; Fratiglioni L; Wang HX
    J Psychiatr Res; 2019 Feb; 109():1-9. PubMed ID: 30453181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive profile of ketamine-dependent patients compared with methamphetamine-dependent patients and healthy controls.
    Wang LJ; Chen CK; Lin SK; Chen YC; Xu K; Huang MC
    Psychopharmacology (Berl); 2018 Jul; 235(7):2113-2121. PubMed ID: 29713787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Cognitive Outcomes of Clinical Phenotypes of Late-Life Depression.
    Riddle M; Potter GG; McQuoid DR; Steffens DC; Beyer JL; Taylor WD
    Am J Geriatr Psychiatry; 2017 Oct; 25(10):1123-1134. PubMed ID: 28479153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive Effects of Ketamine and Esketamine for Treatment-Resistant Major Depressive Disorder: A Systematic Review.
    Souza-Marques B; Santos-Lima C; Araújo-de-Freitas L; Vieira F; Jesus-Nunes AP; Quarantini LC; Sampaio AS
    Harv Rev Psychiatry; 2021 Sep-Oct 01; 29(5):340-350. PubMed ID: 34366408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later.
    Curran HV; Morgan C
    Addiction; 2000 Apr; 95(4):575-90. PubMed ID: 10829333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the nature of objective and perceived cognitive impairments in depressive symptoms and real-world functioning in young adults.
    Dhillon S; Videla-Nash G; Foussias G; Segal ZV; Zakzanis KK
    Psychiatry Res; 2020 May; 287():112932. PubMed ID: 32272334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.